Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Obtains Approval By Crucell's Boards For Proposed Purchase

This article was originally published in The Pink Sheet Daily

Executive Summary

Acquisition would add vaccines to J&J's diverse empire, and make it the sixth-largest player in that space.

You may also be interested in...



J&J's Bid For Crucell Hits Speed Bump With Shipment Suspension At Korean Vaccine Plant

Johnson & Johnson's acquisition offer for Crucell appears to be on track despite news that the Dutch biotech firm suspended all shipments of hepatitis B vaccine Hepavax-Gene and childhood pediatric vaccine Quinvaxem due to issues at its Korean unit Berna Biotech Korea.

J&J's Bid For Crucell Hits Speed Bump With Shipment Suspension At Korean Vaccine Plant

The acquisition appears to be on track despite news that the Dutch biotech suspended all shipments of hepatitis B vaccine Hepavax-Gene and childhood pediatric vaccine Quinvaxem due to issues at its Korean unit.

J&J's Bid For Crucell Hits Speed Bump With Shipment Suspension At Korean Vaccine Plant

The acquisition appears to be on track despite news that the Dutch biotech suspended all shipments of hepatitis B vaccine Hepavax-Gene and childhood pediatric vaccine Quinvaxem due to issues at its Korean unit.

Related Content

Topics

UsernamePublicRestriction

Register

PS071400

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel